Dishon, Shira
Schumacher, Adi
Fanous, Joseph
Talhami, Alaa
Kassis, Ibrahim
Karussis, Dimitrios
Gilon, Chaim
Hoffman, Amnon
Nussbaum, Gabriel
Article History
Received: 1 February 2018
Accepted: 4 June 2018
First Online: 21 June 2018
Competing Interests
: The published PCT application WO 2017/212477 covering backbone cyclized inhibitory peptides of MyD88 was filed in the name of Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd., with G.N., A.H., and C.G. as inventors. The remaining authors declare no competing interests.